AML-299 Azacitidine in Combination With Venetoclax for Myelodysplastic Syndrome (MDS) With Increased Blasts-2 in Clinical Practice Setting

Autor: Davainiene, Birute, Cepulyte, Ruta, Trociukas, Igoris, Pileckyte, Regina, Griskevicius, Laimonas, Zucenka, Andrius
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 1:S287-S287
Databáze: ScienceDirect